From 2000 to 2015, those without insurance or usual care were less likely to have undergone screening
TUESDAY, Aug. 7, 2018 (HealthDay News) — There are persistent disparities in recommended cancer screening tests among U.S. adults, particularly among the uninsured, according to a study published online July 26 in the U.S. Centers for Disease Control and Prevention’s Preventing Chronic Disease.
Ingrid J. Hall, Ph.D., M.P.H., from the CDC in Atlanta, and colleagues used 2000 to 2015 data from the National Health Interview Survey to examine trends in the prevalence of cancer screening that adhered to U.S. Preventive Services Task Force screening recommendations.
The researchers found that over the study period, colorectal cancer screening was the only test that increased. There were disparities in the prevalence of test use among subgroups for all tests examined. No contact with a doctor in the past year, no usual source of health care, and no insurance coverage were associated with reduced use of screening tests.
“Understanding use of cancer screening tests among different population subgroups is vital for planning public health interventions with potential to increase screening uptake and reduce disparities in cancer morbidity and mortality,” the authors write.
.jpg)
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers 
Personalized Support Boosts Families" Genetic Testing for Hereditary Cancers 
Urine Cell-Free RNA Shows Promise as Biomarker for Bladder Cancer 
Age-, Joint-Specific Ultrasound Reference Values Set for Healthy Joints 
Holding DMARDs at Time of COVID-19 Vaccine Not Warranted in Those With Inflammatory Arthritis 
Lower Vertebral Bone Mineral Density Linked to Cognitive Decline 
Disparities Identified in Home Health Care After Hip, Knee Replacement 
Drug Retention in Spondyloarthritis Varies With Socioeconomic Status 
